Site-specific radiation dosage and implant survival in oral cancer patients: A cohort study
- PMID: 37983849
- DOI: 10.1111/odi.14813
Site-specific radiation dosage and implant survival in oral cancer patients: A cohort study
Abstract
Objectives: We assessed the radiation dosages (Dmean) on implant regions to identify the threshold for implant loss in patients with an intraoral malignancy treated with dental implants to support a mandibular denture during ablative surgery before volumetric-modulated arc therapy (VMAT).
Materials and methods: Data was collected prospectively from 28 patients treated surgically for an intraoral malignancy, followed by postoperative radiotherapy (VMAT) and analyzed retrospectively. Patients received 2 implants in the native mandible during ablative surgery. Implant-specific Dmean values were retrieved from the patients' files. Radiographic bone loss was measured 1 year after implant placement and during the last follow-up appointment. Implant survival was analyzed with the Kaplan-Meier method. Univariate logistic regression and Cox-regression analyses were performed to investigate the effect of increasing implant-specific radiation dosages on implant loss.
Results: Five out of 56 placed implants were lost during follow-up (median 36.0 months, IQR 39.0). Radiographically, peri-implant bone loss occurred in implants with a Dmean > 40 Gy. Implant loss occurred only in implants with a Dmean > 50 Gy.
Conclusion: An implant-specific Dmean higher than 50 Gy is related to more peri-implant bone loss and, eventually, implant loss.
Keywords: Oral cancer; dental implants; implant survival; implant‐specific dose; radiotherapy.
© 2023 The Authors. Oral Diseases published by Wiley Periodicals LLC.
Comment in
-
Comment on "Site-specific radiation dosage and implant survival in oral cancer patients: A cohort study".Oral Dis. 2024 Oct;30(7):4794-4795. doi: 10.1111/odi.14889. Epub 2024 Feb 20. Oral Dis. 2024. PMID: 38376124 No abstract available.
-
Authors' reply "Site-specific radiation dosage and implant survival in oral cancer patients: A cohort study".Oral Dis. 2024 Oct;30(7):4796-4797. doi: 10.1111/odi.14888. Epub 2024 Feb 20. Oral Dis. 2024. PMID: 38376125 No abstract available.
References
REFERENCES
-
- Alberga, J. M., Korfage, A., Bonnema, I., Witjes, M. J. H., Vissink, A., & Raghoebar, G. M. (2020). Mandibular implant placement after teeth removal in head and neck cancer patients. Supportive Care in Cancer, 28(12), 5911–5918.
-
- Alberga, J. M., Vosselman, N., Korfage, A., Delli, K., Witjes, M. J. H., Raghoebar, G. M., & Vissink, A. (2021). What is the optimal timing for implant placement in oral cancer patients? A Scoping Literature Review. Oral Diseases, 27(1), 94–110.
-
- Chrcanovic, B., Albrektsson, T., & Wennerberg, A. (2014). Dental implants in irradiated versus nonirradiated patients: A meta‐analysis. Head and Neck, 36(10), 1391.
-
- Curi, M. M., Condezo, A. F. B., Ribeiro, K. D. C. B., & Cardoso, C. L. (2018). Long‐term success of dental implants in patients with head and neck cancer after radiation therapy. International Journal of Oral and Maxillofacial Surgery, 47(6), 783–788.
-
- Gupta, T., Agarwal, J., Jain, S., Phurailatpam, R., Kannan, S., Ghosh‐Laskar, S., Murthy, V., Budrukkar, A., Dinshaw, K., Prabhash, K., Chaturvedi, P., & D'Cruz, A. (2012). Three‐dimensional conformal radiotherapy (3D‐CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: A randomized controlled trial. Radiotherapy and Oncology, 104(3), 343–348.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
